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Abstract:  
This research study aims to shed light on the biomedical approach to HIV prevention and 
in particular PrEP is investigated. Three research questions sought to answer the role of 
PrEP plays in HIV prevention, the challenges regarding PrEP that a nurse faces when 
encountering patients of high risk of HIV and how those problems can be solved.  
 
The study adopts the HIV prevention continuum model by Horn T et al. (2016). Only half 
of the model for HIV negative patients was used which was the primary HIV prevention 
process that focuses on HIV testing, risk and needs assessment; linkage to prevention 
services as well as retention, engagement and adherence.  
 
A literature review based on secondary data was carried out for investigating the research 
questions. By adopting inclusion and exclusion criteria for the keywords chosen for data 
collection, 10 articles were selected from 235 items across a variety of scientific 
databases. The keywords used for selection criteria are PrEP, HIV, HIV prevention, Oral 
pre-exposure Prophylaxis, Nursing, Healthcare Providers, and Transgender. All articles 
were filtered to be after 2012 since that was the year the FDA approved PrEP. After data 
collection, inductive approach of qualitative content analysis by Graneheim & Lundman 
(2004) was used for data analysis.  
 
The findings manifest that PrEP is effective in HIV prevention for those vulnerable to the 
infection which, to name a few, are MSM, Transgender, heterosexual women, IDUs, sex 
workers and those in discordant relationships. Moreover, there were challenges regarding 
PrEP faced by both the patients and the HCPs. The typically identified challenges were 
adherence, cost, mistrust, drug resistance, risk compensation, etc. The measures taken to 
counteract these obstacles that nurses should adopt as discussed, are thorough need & 
risks assessment, referring the patients to HIV prevention services like mental health 
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services, STI clinics, specific community, etc. In addition, nurses are recommended to 
build trust with the patients, provide accurate information about PrEP, set reminders such 
as phone calls and text messages for pill taking and follow up, provide feedback and 
counseling as well as cooperating with social workers.  
 
One of the limitations of this study is that HIV prevention methods are predicted to 
change in the future which may supercede some concepts described in this paper. More 
research is recommended to look at the model by Horn T et al. (2016) as a whole and/or 
incorporate the concepts of behavioral interventions, biomedical interventions and 
structural interventions into the study.  
Keywords: Oral PrEP, Pre-exposure Prophylaxis, HIV prevention, 
Biomedical approach, Biomedical interventions 
Number of pages: 65 
Language: English 
Date of acceptance:  
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PrEP: Pre-exposure prophylaxis 
PEP: Post-exposure prophylaxis 
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1 INTRODUCTION 
WHO (2016) estimated a figure for the year of 2015 that 36.7 million people were 
living with HIV/AIDS while 2.1 million people were recently diagnosed with the 
disease and 1.1 million of mortality incidences derived from HIV injection. The WHO 
also recommends PrEP (Pre-exposure Prophylaxis) which is the method of taking anti-
retroviral drugs for HIV prevention. Would HIV prevention have been more effective if 
there was adequate research on this HIV prevention method from a nursing perspective?  
 
This study aims to shed light on the topics of PrEP in HIV prevention and the relevant 
role of the nurses. Nurses play an essential role in promoting sexual health and 
wellbeing; however, most aspects are not addressed adequately in classroom learning 
and clinical practice (Evans DT, 2013). HIV prevention is an indispensable concept of 
sexual health promotion to be mentioned in this study. Brown JL et al., (2014), 
addressed three biomedical approaches to HIV prevention which are microbicides, 
vaccination, and Pre-exposure Prophylaxis. However, PrEP (Pre-exposure Prophylaxis) 
is the only biomedical approved method for HIV prevention by the FDA and CDC. 
Therefore, this study exclusively focuses on PrEP for HIV prevention from a nursing 
perspective. Le AQ (2017) has noticed that this HIV prevention medication has caught a 
lot of attention in the press recently. PrEP contains tenofovir and emtricitabine 
(TDF/FTC) and has gained approval from the FDA as well as it is supported by the 
Centers for Disease Control (Rowniak S, 2015). Le AQ (2017) also mentioned that 
although PrEP has been legitimately approved, many patients of high risk for HIV 
infections are yet to be informed about the option. He wrote that according to Parsons 
JT et al. (2017) “only fewer than 1 out of 10 eligible for PrEP, according to CDC 
guidelines, were using and adhering to the medicine”.  
Until this point, there is not enough scientific nursing research and articles that address 
adopting PrEP for HIV prevention. This study will investigate the roles of PrEP in HIV 
prevention in nursing practice. 
 
This thesis consists of 9 sections. After the first chapter introducing the topic of the 
research study, the second part sheds light on the background HIV as well as different 
strategies for HIV prevention. Thirdly, a theoretical framework is selected and justified 
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in detail for its suitability for the research. Section 4 reveals the limitations of this study 
whilst section 5 states the aims and the research questions. How the data was collected 
and analyzed as well as what method was adopted is included in section 6 on 
methodology. Section 7 and 8 are respectively the findings from 10 articles and the 
discussion articulated from the findings, background, and theoretical framework. Last 
but not least, section 9 consists of the conclusion and critical discussion which outlines 
the strengths, limitations of this dissertation and recommendations for further nursing 
research in the field HIV prevention. References and Appendixes can be found at the 
end of the text.  
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2 BACKGROUND 
HIV is a virus that gradually attacks the immune system, which is our body’s natural 
defence against illnesses. A person who becomes infected with HIV finds it harder to 
fight off infections and diseases. The virus destroys a type of white blood cell called a 
T-helper cell and makes copies of itself inside the cell. T-helper cells are also referred to 
as CD4 cells (WebMD, HIV).  
 
The World Health Organisation published an astounding trend showing 70 million 
people have contracted the virus worldwide of which 35 million have died from it. A 
general figure shows that roughly 0.8% of adults aged 15–49 years are living with HIV. 
However, the extent and the severity of the burden varies from region to region, 
demographic to demographic (WHO, 2016).  
2.1 HIV prevention methods  
HIV prevention programs aim to protect individuals and communities from HIV 
transmission by using singular or a combination of behavioral, biomedical and structural 
strategies. These strategies are best implemented in places with a high prevalence of 
HIV where the needs of high-risk groups are met. At first, HIV prevention was 
approached from a behavioral change point of view, in which ABC (Abstinence, Be 
Faithful, Use a Condom) was critically emphasized. However, it was not until the mid-
2000s that it was realized that a combination approach to tackle the epidemic was 
needed. The trend of decline in new HIV acquisition between 2010 and 2015 had not 
been optimistic (about 1.9 million new infections each year). The figure depicts a slow 
decline to static numbers of new infections. This trend is ambitiously targeted by 
UNAIDS aiming for below 50,000 new infections by 2020 (Avert, HIV prevention 
programmes overview). 
 
Carrying out a combination of HIV prevention programmes would require the 
community and HCPs to understand their epidemic for the appropriate response. Strong 
community empowerment should be emphasized to address policy barriers, gender 
inequality, stigma, and discrimination. As an example, MSM should be provided with a 
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combination of easy access to condoms, lubricant, PrEP, and programs tackling 
homophobia; whereas IDUs would benefit from NSPs and OST (Avert, HIV prevention 
programmes overview). 
 
Multiple HIV prevention interventions should be practiced by nurses. Firstly, AIDS risk 
reduction education should be given which includes providing the patients with 
evidence-based information about HIV transmission, HIV testing, Safer Sex practices, 
safe injecting drug use (IDU), and an overview of HIV disease. Moreover, nurses are 
bound to correct any misunderstands or misconceptions the patients have regarding HIV 
disease. Secondly, skills building that can be manifested by nurses showing and 
teaching the patients about safer sex practices such as providing information condoms 
and sex negotiation. Thirdly, condom use skills building. This will be by using 
demonstrations by nurses on how to use condoms correctly. Finally, community 
awareness can be strengthened by nurses in the community of patients at high risk for 
HIV. In this way, patients of similar interests, backgrounds and stories can come 
together and support one another (Porche Demetrius J, et al., 2003). 
Moreover, Rowniak S (2015) claimed that nurse practitioners are best suited for 
disseminating information about access to PrEP. The work is to abide by the strict 
protocol of assessing the risk level, sexual history, and drug use as well as current 
medical conditions.  
2.1.1 Behavioral interventions 
Behavioral intervention is achieved when risky sexual behavior is influenced positively 
in order to seek to reduce the chances of contracting HIV. Such behavioral changes are 
a reduction in the number of sexual partners, an increase in the correct and consistent 
use of condoms as well as an increase in the use of clean needles. This is accomplished 
by information provided in the form of sex education, psycho-social support, stigma and 
discrimination reduction programmes, etc. To date, these interventions have accounted 
for most of the success (Coates, T.J et al., 2008). 
 
Moreover, it has been proven that sex education that took place in the school 
environment is deemed as being most effective (IPPF, 2016). Despite the fact that these 
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behavioral interventions have been confirmed as providing a positive impact on the 
outcome of HIV transmission, many countries have not been successfully implementing 
such programmes in recent years. Consequently, in 2015, young people in and outside 
of sub-Saharan Africa still the lack essential knowledge to keep HIV transmission at 
bay. On the side note, programmes promoting abstinence and faithfulness have been 
documented to be subjected to failure in many countries in spite of continuous 
investment (UNAIDS, 2016). 
2.1.2 Biomedical interventions 
Biomedical strategies can be implemented in three phases that are before, during and 
after HIV infection. Male circumcision, vaccination, topical and oral PrEP are said to be 
used before the infection whereas PEP is used during the acute phase of the infection 
and the use of ART as TasP is for after the immediate post-infection stage. At the 
“before the infection phase”, male circumcision has not yet been proven to play any 
critical role in preventing HIV transmission among MSM as well as males who have sex 
with females. Vaccination has failed in many clinical trials phases. Topical PrEP or so-
called microbicide was unable to prove its effectiveness in preventing HIV infection 
during the large-scale trial of 5029 women in South Africa. On the contrary, oral PrEP 
was reported to achieve approximately 96% effectiveness when 4 doses a week were 
adhered in the iPrEX study of 2499 MSM (Chan R, 2012). 
During the immediate acute phase of HIV infection, PEP has been used even before the 
CDC´s approval. It has been evidently effective when used for 28 days starting within 
48-72 hours after the possible exposure to HIV. Similar to PrEP, PEP uptake requires 
repeated HIV testing as well as other relevant blood tests (Chan R, 2012). 
TasP, used after the immediate post-infection phase, can lower the risk of new infection 
for those who come into sexual contact with the HIV positive partner who is on ART 
(Chan R, 2012). 
By focusing mainly on the stage of before HIV infection, these facts act as precursors to 
why only the proven and promising oral PrEP would take center stage of this study. 
 
PrEP (Pre-exposure prophylaxis) 
What is PrEP? 
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PrEP can be considered to prevent contracting HIV for those at high risk of HIV 
acquisition. The brand name Truvada as PrEP is the original medication. The drug 
consists of a combination of two active ingredients which are Tenofovir and 
Emtricitabine. Le AQ (2017) cited from the CDC that “these two active ingredients 
have been used in treating HIV but are also used for HIV prevention. The drug is 
effective in preventing HIV from sexual intercourse or injecting-drug-using partner who 
is HIV positive”. It is evidenced that PrEP is effective in combating the risks of 
contracting HIV if the dosage taken is adhered to strictly. Le wrote “PrEP´s 
effectiveness can be diminished if dose usage is not consistent. The medicine has been 
approved by the FDA and recommended by WHO” (Centers for Disease Control and 
Prevention, PrEp).  
How does PrEP work? 
Le AQ (2017) wrote “Pebody R (2015) compares PrEP action mechanism as similar to 
that of malaria prevention. Antiretrovirals (ARVs) of high levels in the bloodstream can 
form a protective barrier against HIV when PrEP is taken. Consequently, the virus is 
stopped from entering the cells and replicating by the ARVs at the point of 
transmission, thus the person remains HIV negative”. 
How effective is PrEP? 
Le AQ (2017) mentioned that “according to IPrEp OLE study, no individual has been 
found to seroconvert HIV if they adhere to the dosage of 4 times per week 
(recommended daily dosage). Hence the efficacy of PrEp is proven. The study suggests 
99% effectiveness. (Celum C, 2012; Anderson PL et al., 2012)”. The CDC recommends 
taking PrEP daily for maximum effectiveness against HIV-1 infection in MSM, 
heterosexual men and women, IUDs and HIV-1-negative partners in serodiscordant 
couples. However, the IPERGAY study presented by Molina Jean Michel et al., (2015) 
introduced the “on-demand” method of taking PrEP for MSM. The method involves 
dosing PrEP 2-24 hours before sex followed by one pill per day during the consecutive 
episodes of sex and then 2 pills after the last sexual exposure. The study reveals that 
“on-demand” can provide protection as effective as the daily regime given that the 
participants take about 15 pills per month.  
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Despite the efficacy of the drug, David Knox (2016) reported the first case of PrEP 
failure. The culprit was multi-drug resistant strain. It was documented that the person 
adhered to the correct Truvada dose regardless of the drug failure.  
In October 2016, Howard Grossman, an HIV specialist from Cleveland Clinic 
illustrated the second case of PrEp failure. By testing his hair and blood, the patient was 
found to have adhered to the daily dosage. The HIV strain the patient contracted was 
rare and resistant to both of the active ingredients in PrEP (Hiv plus mag, 2016). 
Le AQ (2017) wrote “the third case of PrEP failure was presented by Elske 
Hoornenborg, MD, an infectious disease specialist in Seattle at the Conference on 
Retroviruses and Opportunistic Infection (CROI) in 2017. This case of failure was not 
found to be due to drug resistance. Instead, it was hypothesized that the object was 
exposed continuously to the virus due to high-risk sex lifestyle. Professor Robert M. 
stated that the third case failure is only one of very few cases”. Considering the fact that 
PrEP protects many people PrEP, the ratio of failure is small and PrEP is still effective. 
There is no 100% effective protection method including condoms (Ryan B, 2017) 
2.1.3 Structural interventions 
It is evident that inequalities and prejudices are catalysts for HIV related vulnerabilities 
(UNAIDS, 2016). For instance, firstly, MSM find it harder to access condoms in a place 
where same-sex relationship is criminalised. Secondly, the unequal negotiating power of 
condom use has been documented to be derived from the subordination of women. 
Thirdly, poor infrastructure acts as a precursor to difficulty in accessing health clinics. 
Individuals can better access HIV prevention services when these structural barriers are 
appropriately tackled (Rao G et al., 2008). The suggested interventions for combating 
such obstacles are strengthening the laws to end violence in partnership, increased 
access to education for girls, decriminalising same-sex relationships as well as cross-
dressing and sex work, community empowerment to reduce stigma and discrimination 
especially in healthcare settings. However, structural barriers are much harder to combat 
since they are presented in the form of deep-rooted socio-economic matter such as 
social marginalisation, gender inequality, and poverty (Avert, HIV prevention 
programmes overview). 
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3 THEORETICAL FRAMEWORK 
3.1 The HIV prevention continuum model  
It is said that every potential HIV infection is preventable with the proper approach. The 
HIV prevention continuum model presented by Horn T et al. (2016) is arguably 
pragmatic with the aim of this research. The model is comprehensive with two parts, 
primary and secondary that is applicable for HIV prevention and HIV treatment 
respectively. There may be some limitations to the research for not being able to use the 
second part of the model, but the scope of the study only focuses on preventative 
approaches, so just the primary part of the model is applied despite prevention and 
treatment being closely related. Moreover, the practicality of PrEP is also addressed in 
the proposed model which makes no other models more suitable than this one. The 
framework has recently been accepted in 2016; therefore it is presently relevant to the 
topic of PrEP. It is evidenced that protecting those uninfected but vulnerable to HIV is 
as important as treating and suppressing viral load of those HIV infected patients. The 
model has been proven to be reproducible and particularly relevant to PrEP. (Horn T et 
al., 2016). While half of the model represented below only concerns those who are 
uninfected but vulnerable to HIV, the whole model is placed in the index section.  
 
 
Figure 1 Primary HIV prevention (reduction of acquisition risk) of the HIV prevention continuum model  
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The HIV prevention continuum model is said to be useful to identify best biomedical, 
behavioral approaches and connect support from health promotion, primary care, and 
reproductive services. It also helps pinpoint the gaps to allocate the best possible 
resources for HIV prevention. The individualized preventative needs can be met with 
the help of the model. Implementing the model could potentially result in a reduction of 
HIV acquisition within the whole population. (Horn T et al., 2016) 
3.2 HIV testing and retesting  
The key player in this prevention cycle is repeated HIV testing. The vulnerable would 
be continuously tested for 2 case scenarios. The point of testing acts as a critical point of 
contact for both the patients and the service providers. If the patient remains HIV 
negative, they would be subjected to a suitable preventative plan and retest until the 
patient is not susceptible to virus acquisition anymore. However, a confirmed positive 
result will be dealt with by proper treatment. The integrity of the model only works if 
testing is performed frequently enough to exclude those who seroconvert from the 
primary preventative measures so they can move onto secondary HIV prevention (as 
seen from the whole model in the index). (Horn T et al., 2016) 
3.3 Risk and needs assessment  
Following a negative test result, those vulnerable to HIV are recommended to receive 
thorough risk and needs assessment to stay negative. Identifying the potential risk based 
on the patient´s individual circumstance is essential when determining the evidenced-
based interventions and social services for the given the assessed risks. One´s situation 
can change, and therefore, this procedure needs to be repeatedly performed in response 
to ever-changing HIV prevention requirements. For example, if a patient is tested in an 
acute care or non-healthcare settings, a set of risk and needs assessment must be 
performed before referring them to other appropriate HIV healthcare settings for HIV 
preventative approaches such as screening for STIs, drug abuse, mental health disorders, 
violence or trauma, etc. There are risks and needs assessment tools that are simple to 
use in which one can get access to online. PrEP can be recommended as one of 
preventative needs for those at high risk of HIV acquisition. (Horn T et al., 2016) 
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3.4 Linkage to prevention services 
Risks and needs assessments can be done either in primary care settings or acute and 
non-primary care settings. Following a comprehensive risk and needs assessment in a 
primary care setting, an individual is referred to a suitable facility that caters for their 
personal HIV preventative needs. Such facilities can be in the field of substance abuse, 
mental health, medical, psychosocial and ancillary services provided by CBO. Those 
who were served in an acute or non-primary healthcare setting can be referred to 
appropriate primary settings with medical expertise in HIV prevention for sexual health, 
reproductive, transgender as well as those clinics that provide PrEP for high-risk 
patients. If the patient is a candidate for PrEP and some services, linkage to medical 
coverage or/and other suitable aiding programs should be advised. (Horn T et al., 2016) 
3.5 Engagement, retention and adherence 
Finally, the effectiveness of primary prevention cycle is determined by how well the 
patients engage and adhere to HIV prevention interventions. Among other approaches 
such as Post-exposure prophylaxis (PEP); substance abuse treatment; mental health 
services; syringe exchange programmes (SEPs); PrEP is to be considered seriously with 
competent client-centered services. (Horn T et al., 2016) 
3.6 Summary 
This chapter sheds light on the theoretical framework used to prevent primary HIV 
infection. The section demonstrates that the primary HIV prevention part of the HIV 
prevention continuum model, depicting in a continuous process, contains 4 phases of 
HIV testing namely: HIV testing; risk and needs assessment; linkage to prevention 
services; engagement, retention and adherence.  
The 4 steps are to be repeated in order until the patient is no longer susceptible to the 
risk of HIV acquisition. The theoretical framework provides linkage between HIV 
prevention, PrEP and nursing theories. In other words, the model by Horn T is suitable 
for nursing´s implementation of delivering HIV preventative services in general and 
PrEP in particular.  
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4 LIMITING THE SCOPE OF THE STUDY 
Given the scope of 10 articles to analyse, it would be impossible to cover all aspects of 
HIV prevention in a bachelor thesis. Therefore, this dissertation only focuses on HIV 
biomedical interventions in which PrEP is the only approved method out of 
microbicides, vaccines and PrEP. Although PEP is approved, it is preferably an 
emergency and during immediate infection approach to possible HIV exposure which 
disqualifies it from this study´s scope that emphasizes on regular basis intervention. 
Therefore, the following aims and analysis would only delve into the topic of PrEP and 
the relevant roles of the nurses.  
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5 AIM AND RESEARCH QUESTIONS 
This study has the purpose of making sense of the complex relationship between PrEP 
and HIV prevention. Furthermore, the nursing role is to be examined in PrEP and HIV 
prevention.  
 
Through a process of critical evaluation, the author aims to find answers to the two 
following research questions:  
1. What roles does PrEP play in HIV prevention?  
2. What are the challenges regarding PrEP, that nurses face when encountering 
patients with high risk for HIV acquisition?  
3. What are the recommendations to combat the challenges regarding PrEP, that 
nurses face during care encounter?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 19 
 
6 METHODOLOGY 
Literature review seeks to establish a tool for one´s own research through the previous 
work demonstrated by others (University of Sydney, 2016). Al-busaidi (2008) noted 
that one of the common resources of literature review is published academic journals 
and it is a justified method used in health-related study as well as phenomenology. 
Therefore, literature review is best suited for this study. Once academic data is 
collected, inductive content analysis is deployed for this literature review. Firstly, the 
chapter represents the methods and process of how the data was collected. Secondly, 
qualitative content analysis of data after collection is based on the method of Graneheim 
and Lundman (2004). Despite having a well-grounded theoretical framework to hang on 
to and clear research questions to start off with, the inductive content analysis was 
chosen instead of deductive counterpart because the author wanted to read the whole 
texts of the selected articles open-mindedly. Inductive approach allows the author to 
find more relevant information without being confined in the boundaries of the research 
model. Although this method had cost more time, it is believed that the resultant 
findings are more detailed compared to what a deductive approach could have offered.  
6.1 Data collection 
The author made use of the search engines available for nursing students at Arcada 
University of Applied Sciences. The search for articles was done through Academic 
Search Elite (EBSCO), Cinahl (EBSCO), Cochrane Library, PubMed, Sage, and 
ScienceDirect. The timeframe for all search engines is filtered from 2012 to present 
since PrEP was only approved by the FDA in 2012. The author made a plausible 
assumption those articles about PrEP before 2012 would not be as updated about the 
topic as articles produced after that date. Search in all search engines was done with 
“Advanced Search”.  
 
Firstly, Academic Search Elite (EBSCO) was used with search keywords of “PrEP” 
AND “HIV prevention” AND “Nurse”. All keywords were in “Optional field”. The 
search was limited to peer-reviewed which resulted in 10 hits. After that, after the titles 
and abstracts of 10 articles were read, the author applied pre-inclusion and exclusion 
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criteria to eliminate those that are not clearly relevant to the research questions and 
those without relevant keywords. Finally, 3 articles were chosen for further scrutiny. To 
widen the results of the search, the author performed the same search on the same 
engine again without the keyword “Nurse” and replaced “PrEP” with “oral Pre-
exposure Prophylaxis”. The search was set to full text. The rationale behind this is that 
the author wants to research PrEP from a variety of perspectives, the keyword “nurse” 
or “nursing might limit the scope of the results. “Oral Pre-exposure Prophylaxis” is 
another synonym for PrEP. After the second search of the same database, 24 hits came 
up. Again applying pre-inclusion and exclusion criteria would result in 4 articles being 
chosen for the next round of scrutiny. 
Secondly, Cinahl (EBSCO) was used. The keywords were “PrEP” AND “HIV 
prevention”. The search was confined to linked full text, academic journals, and English 
language. Pre-inclusion and exclusion criteria were applied, and out of 32 results, 4 
were selected. 
Thirdly, the search through Cochrane Library was conducted similarly to the second 
search engine which yielded only 1 result. The article was chosen.  
Fourthly, the search through PubMed included keywords in “All Fields” such as “PrEP” 
AND “HIV prevention” AND “Nursing”. The search was confined to review and free 
full text which yielded only 3 results. No article was chosen after pre-inclusion and 
exclusion criteria. The author tried again with keywords “PrEP” AND “HIV 
prevention” AND “Healthcare providers”. The reason for this is that nurses are also 
included in the healthcare providers group. This would give a wider range of results. 11 
hits appeared in which 2 were chosen. To widen the scope more, only keywords “PrEP” 
AND “HIV prevention” were entered. Out of 86 results, 4 were chosen.  
Next, the search through Sage Journal for review articles only yielded 9 results for 
keywords “PrEP” AND “HIV prevention”. The search was limited to 2012 – 2017 and 
review article. None of the articles were chosen.  
Science direct was the final attempt at data retrieval. Journals and review articles were 
selected, and keywords were searched in “All Fields”. Since many of the articles 
included nursing elements already, only keywords “PrEP” AND “HIV” were entered 
with limitation to “PrEP” and “HIV prevention”. 3 articles were chosen from 34 hits. 
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After looking through all the short-listed articles, none had content about transgender 
which is one of the groups at risk for HIV acquisition. The author made one last attempt 
with Science Direct with keywords “PrEP” AND “Transgender”. Out of 25 articles, 
only 1 was short-listed derived from the application of pre-inclusion and exclusion 
criteria.  
6.1.1 Implementation of inclusion and exclusion criteria  
22 articles made a shortlist to the second round of selection for the inclusion and 
exclusion process. In this phase, all articles were read, and those not in line with the 
inclusion and exclusion criteria were disqualified. 10 articles were chosen which means 
12 were eliminated. The inclusion criteria are as follow:  
1. How relevant the article is to the research questions.  
2. The article ought to be related to at least 2 out of 3 research questions.  
3. To what extent the article is consistent with the HIV prevention model that can be 
interpretable to nursing practice. 
The data process depicted in table 1 consists of a selection of search engines, keywords 
as well as the implementation of inclusion and exclusion criteria. 
Table 1 Data collection processes and implication of inclusion & exclusion criteria 
 Search Engine Keywords Limitation Hits Short-listed 
1 
Academic Search Elite 
EBSCO 
“PrEP” AND “HIV 
prevention” AND 
“Nurse” in “Optional 
field” 
Peer reviewed 
2012 - present 
10 3 
“Oral Pre-exposure 
Prophylaxis” AND 
“HIV prevention” 
Peer reviewed 
Full text 
2012 - present 
24 4 
2 Cinahl (EBSCO) 
“PrEP” AND “HIV 
prevention” in 
“Optional field” 
Linked full text 
Academic Journals  
English language 
2012 - present 
32 4 
3 Cochrane Library “PrEP” AND “HIV 
prevention” in “Title, 
None 
1 1 
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abstract”  
4 PubMed 
“PrEP” AND “HIV 
prevention” AND 
“Nursing” 
In “All Fields” 
Review 
Free full text 
5 year 
3 0 
“PrEP” AND “HIV 
prevention” AND 
“Healthcare 
providers” 
In “All Fields” 
Review 
Free full text 
5 year 
11 2 
“PrEP” AND “HIV 
prevention” 
In “All Fields” 
Review 
Free full text 
5 year 
86 4 
5 Sage Journal 
keywords “PrEP” 
AND “HIV 
prevention” 
Review article  
2012-2017 
9 0 
6 Science Direct 
“PrEP” AND “HIV” 
in “All Fields” 
Journals 
Review articles 
“PrEP” 
“HIV prevention” 
2012 – present  
34 3 
“PrEP” AND 
“Transgender” in “All 
Fields” 
Journals 
Review articles 
25 1 
Total    235  22 
Process order and 
Rationale 
1 
Pick the search 
engines are available 
for nursing students at 
Arcada UAS. 
2 
The author tried to 
increase the results by 
entering different 
keyword synonyms 
and combinations 
3 
All articles should be 
recent and peer-
reviewed. 
4 
Applying the pre- 
inclusion and 
exclusion criteria 
by reading titles 
and abstracts 
5 
From the short-listed 
articles, Implementing 
the inclusion and 
exclusion criteria to 
pick out 10 last 
articles. 
 
6.2 List of articles chosen for the study 
1. Auerbach, J, Kinsky, S, Brown, G, & Charles, V 2015, 'Knowledge, Attitudes, 
and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at 
 23 
 
Risk of Acquiring HIV', AIDS Patient Care & Stds, 29, 2, pp. 102-110, 
Academic Search Elite, EBSCOhost, viewed 4 April 2017. 
2. Poteat, T, Wirtz, A, Radix, A, Borquez, A, Silva-Santisteban, A, Deutsch, M, 
Khan, S, Winter, S, & Operario, D 2015, 'HIV risk and preventive interventions 
in transgender women sex workers', Lancet, 385 North American Edition, 9964, 
pp. 274-286, CINAHL, EBSCOhost, viewed 3 April 2017. 
3. McMahon, J, Myers, J, Kurth, A, Cohen, S, Mannheimer, S, Simmons, J, 
Pouget, E, Trabold, N, & Haberer, J 2014, 'Oral Pre-Exposure Prophylaxis 
(PrEP) for Prevention of HIV in Serodiscordant Heterosexual Couples in the 
United States: Opportunities and Challenges', AIDS Patient Care & Stds, 28, 9, 
pp. 462-474, Academic Search Elite, EBSCOhost, viewed 3 April 2017. 
4. Alistar, S, Owens, D, & Brandeau, M 2014, 'Effectiveness and Cost 
Effectiveness of Oral Pre-Exposure Prophylaxis in a Portfolio of Prevention 
Programs for Injection Drug Users in Mixed HIV Epidemics', Plos ONE, 9, 1, 
pp. 1-11, Academic Search Elite, EBSCOhost, viewed 5 April 2017. 
5. Sybil G. Hosek, HIV Pre-Exposure Prophylaxis Diffusion and Implementation 
Issues in Nonclinical Settings, American Journal of Preventive Medicine 2013, 
Volume 44 , Issue 1 , S129 - S132 
6. Rowniak, S 2015, 'PrEP: A case study', Journal Of The American Association 
Of Nurse Practitioners, 27, 6, pp. 296-299, Academic Search Elite, EBSCOhost, 
viewed 7 April 2017. 
7. Krakower DS, Mayer KH. The Role of Healthcare Providers in the Roll-Out of 
PrEP. Current opinion in HIV and AIDS. 2016;11(1):41-48. 
doi:10.1097/COH.0000000000000206. 
8. Eaton L, Driffin D, Bauermeister J, Smith H, Conway-Washington C. Minimal 
Awareness and Stalled Uptake of Pre-Exposure Prophylaxis (PrEP) Among at 
Risk, HIV-Negative, Black Men Who Have Sex with Men. AIDS Patient Care & 
Stds [serial online]. August 2015;29(8):423-429. Available from: Academic 
Search Elite, Ipswich, MA. Accessed April 2, 2017. 
9. Haire BG., Preexposure prophylaxis-related stigma: strategies to improve uptake 
and adherence – a narrative review. HIV/AIDS (Auckland, NZ). 2015;7:241-
249. doi:10.2147/HIV.S72419. 
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10. Marcus, J, Buisker, T, Horvath, T, Amico, K, Fuchs, J, Buchbinder, S, Grant, R, 
& Liu, A 2014, 'Helping our patients take HIV pre-exposure prophylaxis (PrEP): 
a systematic review of adherence interventions', HIV Medicine, 15, 7, pp. 385-
395, Academic Search Elite, EBSCOhost, viewed 8 April 2017. 
6.3 Content analysis 
Hsui-Fang & Shannon (2005) and Graneheim & Lundman (2004) both offer a few 
different choices for qualitative content analysis. According to Hsui-Fang & Shannon 
(2005), the conventional content analysis is inductive whereas directed content analysis 
follows deductive approach. The third method of the author is summative content 
analysis which seeks to deep analyse by identifying and assessing the quality of specific 
words or phrases within the text.   
 
The qualitative content analysis proposed by Graneheim & Lundman (2004) is adopted 
in this study due to its relevance in nursing research and caring by nature. This method 
is conducted inductively by reading the whole article several times to comprehend the 
big picture. The process of the analysis is followed by condensing, coding and 
classifying the meaning units to group them into categories. The categories resemble the 
main points of the unit of analysis (the text of the article) in which its content is 
depicted.  
 
Graneheim & Lundman (2004) claimed that the content of qualitative data should be 
classified, evaluated and objectively tested in organised processes. The terms used in 
this approach are of following:  
Manifest content represents the apparent and obvious meaning of the text while latent 
meaning is the interpreted and underlying meaning of the passage. Unit of analysis is 
the equivalent to that of the whole text in an article. Meaning units are the content of 
related words, sentences, and paragraphs. Condensation involves briefing of meaning 
units without jeopardizing the main points while abstraction is used for describing, 
interpreting and creating codes, categories, and themes. When pointing out specific 
parts of the transcript, one would be referring to the content area. Code plays an 
essential role in labeling a meaning unit.  A category is formed when several codes of 
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similar content are placed together. Two or more sub-categories (minor categories) may 
be present in the main category (major category). Finally, the formation of themes and 
sub-themes is the result of interpretation and underlying meaning as well as describing 
the latent meaning of the unit of analysis.  
6.3.1 Step 1: reading and coding  
10 articles were chosen after some thorough reading and applying inclusion as well as 
exclusion criteria for 22 articles. Thereafter, more careful reading of the 10 articles was 
carried out where highlights and notes of relevant information were marked on the 
papers. Within a content area, keywords as labeling codes were used in conjunction 
with aiding highlighting, underlying, stars or signs for the ease of dissecting the text. 
The modifications marked on papers manifested the parts that were important and 
relevant to this research which helped the author prepare for step 2.  
6.3.2 Step 2: listing and categorising the codes 
First, the information marked on the margin was listed in a table for further analysis of 
its meaning. Then, after comprehension, the data information was coded and placed in 
relevant categories in which no code was found in more than one category.  
 
An example of coding and categorizing is represented in which each step of precedence 
takes place from left to right (Meaning unit, Condensed meaning unit, Latent meaning, 
Codes, and Categories) in table 3 in Appendix 2. As can be seen, 3 categories have 
resulted from 11 meaning units. The meaning unit was transcribed precisely from the 
text and then condensed so that it appears as briefly as possible without losing the 
central meaning of the manifest content. When interpretation took place, latent content 
depicted the underlying meaning of the whole context. Finally, each meaning unit was 
coded based on the latent meaning. Categories were formed based on the codes of 
similar characteristics.  
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Take note that table 3 in Appendix 2 shows how inductive qualitative content analysis 
was carried out in this research while table 4 in Appendix 3 manifests how major and 
minor categories were derived from 10 chosen units of analysis.  
6.3.3 Sub-themes and theme  
The table below briefly represents the theme, sub-themes, major categories, and unit of 
analysis of the analysis of the chosen articles. A more in-depth of minor categories and 
their findings can be found in table 6 appendix 5.  
Table 2 Common categories and themes derived from 10 unit of analysis 
Theme PrEP in HIV prevention and the role of HCPs 
Sub-themes Risk & needs assessment Challenges 
 
Recommendation for 
HPCs 
Major 
categories 
HIV risk Information about 
PrEP 
Challenge faced by 
patients 
Challenge faced by 
HCPs 
Unit of 
Analysis 
1, 2, 3, 4, 5, 6, 7, 
8, 9, 10 
1, 2, 3, 4, 5, 6, 7, 8, 
9, 10 
1, 2, 3, 4, 6, 7, 9 3, 6, 7, 9 1, 2, 3, 4, 5, 6, 7, 8, 9, 
10 
6.4 Ethical aspects of the research study 
As stated by Angelica et al. (2000) every piece of research can encounter some ethical 
issues and there are two ethical aspects to be mentioned in this section. First is the 
unravelling of how well standards were followed concerning copyrights, writing and 
data analysis. Fry & Johnstone (2012) noted that nursing ethics are overseen by a 
system of standards and principles in which actions and function are guided based on 
the sort of allowed, compulsory and forbidden behaviors as well as conducts. Second is 
the clarification about the independence between the author and the Gilead, the 
pharmaceutical company that originally produces PrEP.  
 
The materials used in this research are from open sources database and paid database for 
the students of Arcada University of applied sciences in which the author has access to. 
As a result, no violation of copyrights or falsified materials was ensured. Moreover, 
original content was produced to the extent that most sources were adequately 
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paraphrased (except for the meaning unit of inductive qualitative content analysis where 
the sentences had to be kept exactly as the original), correctly cited and referenced 
according to Harvard referencing style. The quotations used in some of the passages are 
cited from the bachelor thesis of the same Author that wrote this paper. Furthermore, the 
data used for analysis were extracted from credible sources like WHO, UNAIDS, CDC 
and peer-reviewed articles. This establishes a sense of credibility of the research´s 
quality and the author´s bias was minimized to a great extent. No personal information 
from any studies or materials were brought to light except for those from open public 
sources like the video found on Youtube that is mentioned later in the discussion part.  
 
The study carries a disclaimer about the author being sponsored by any commercials or 
companies. In other words, this research is entirely independent of financial or any 
promotional incentives. The reason why oral PrEP was chosen as the case study is 
because this medicine is the only approved and proven biological method regarding 
effectiveness to prevent HIV acquisition. Other biological methods like vaccine and 
microbicides are either not supported nor of proven effectiveness. Moreover, the scope 
of the study does not allow the author to investigate more into other biological 
approaches in different stages of HIV infection like PEP and TasP because the focus is 
on the before infection phase of how HIV acquisition can be kept at bay.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 28 
 
7 FINDINGS 
7.1 Risks associated with HIV 
This section highlights the major category of HIV risks found in the 10 analyzed 
articles.  
Gender and sexuality: Women, MSM and transgender are statistically proven to be at 
high risk of HIV. The result of the degree of risk can vary depending on where and 
when the study was done. Auerbach J et al., (2015) noted that roughly 25% of HIV 
positive people in the US are women and they accounted for 20% of new infection in 
2011, in which the majority of them practiced heterosexual sex. The statistics are not 
much better for transgender women. Worldwide, nearly 1 in 5 (19.1%) TSW live with 
HIV which accounts for 27.3% of HIV prevalence. The HIV risk factors of a 
transgender person consists of a combination of many things such as biological factor 
(hormone treatment, silicone injection), having high-risk male partners, discrimination, 
violence, etc. (Poteat T et al., 2015). The number is astounding in men who have sex 
with men. Nearly half (48%) of HIV positive individuals are MSM, and they account 
for 53% of new transmissions. Despite the large prevalence of HIV in MSM, they 
comprise only about 3% of the male gender. It was noted that MSM are 44 times more 
likely to be diagnosed with HIV compared to other men. These statistics were 
mentioned in Eaton L et al., (2015)´s study regarding MSM in the USA. Similarly, the 
group at risk for HIV is MSM which is documented in the study of Krakower DS & 
Mayer KH (2016). [1, 2, 3, 5, 7, 8, 9]. 
 
Race: Despite only 13% of black women representing the American female population, 
64% of new infections among women are found in black/African women. That makes 
black women 20 times more prone to HIV infection compared to white women in 
America. The statistic for Hispanic/Latina women is slightly better with a 4 times higher 
infection rate compared to white American women (Auerbach J et al., 2015). In another 
paper, African and Latina women account for 81% of HIV positive women while they 
only represent 27% of the female population in the US. This paper also referenced a 
study from Wilson et al., (2003) that Latina women in California are 6 times more likely 
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to contract HIV with a primary partner compared to those with non-primary partners 
(McMahon J et al., 2014). Rowniak S, 2015 also noted that the demographic of young 
MSM of color is showing a trend of increasing HIV infection in the US. Regarding the 
demographic of MSM, Black MSM (BMSM) are 6 times more likely to be diagnosed 
with HIV compared to white MSM. In other words, BMSM are the most at risk of HIV 
in the US (Eaton L et al., 2015). [1, 3, 6, 8]. 
 
Risky Behaviors: Prostitution is represented by an estimation of 24 to 75% of the 
transgender population in the USA. The number is slightly higher for Asian transgender 
women with 54 – 80% of history with prostitution. Moreover, data has shown that 
partners of TSW involved in high-risk drug activities such as drug injection, drug 
purchasing, etc. TSW were found to engage in sex without condoms with partners more 
than sex with clients. This could also put them at other risks like substance misuse 
(Poteat T et al., 2015). HIV – negative partners within serodiscordant couples are one of 
the high-risk groups for HIV according to McMahon J et al., (2014). Another group at 
high risk for HIV is IDUs. The act of injecting drugs does not provide HIV protective 
measure when condoms and clean needles are not an option. In addition, needle sharing 
was prevalently found in IDUs with high-risk behaviors which act as a precursor to HIV 
infection (Alistar S et al., 2014). IDUs are also mentioned in the group at high risk for 
HIV in the journal of Krakower DS & Mayer KH (2016). Rowniak S, 2015 stated that 
high-risk behaviors were also abundantly documented in MSM, many admit that 
condoms are not an option for them despite having frequent multiple changes of sexual 
partner. Another study of his in 2009 observed individuals who developed a fatalism 
attitude towards HIV, in which wearing condoms is out of their equation of sexual 
practice (Rowniak S, 2009). [2, 3, 4, 6, 7, 9, 10]. 
7.2 Information about PrEP  
In this section, the findings of information about PrEP from 10 articles are presented.  
PrEP benefits: All 10 articles mention about the benefits of PrEP being effective at HIV 
prevention based on evidence from FDA approval, CDC guidelines and WHO´s 
recommendation. [1, 2, 3, 4, 5, 6, 7, 8 ,9, 10].   
PrEP knowledge from patients: Low according to article 1, 5 and 8. Auerbach J et al., 
 30 
 
2015 conducted a focus group interview about PrEP knowledge among US women who 
are at high risk of acquiring HIV and yielded a shocking result of less than 10% had 
ever heard of PrEP.  Many of them were displeased for not having known nor learned 
about the option. It is also mentioned that knowledge about PrEP among communities 
prone to HIV is very low (Sybil G. Hosek, 2013). The awareness of PrEP in the Black 
MSM community is shallow (Eaton L et al., 2015). [1, 5, 8].  
PrEP knowledge from HCPs: Low to medium. Articles 1, 5, 6, 8 presented the findings 
as low, and article 7 presented it as medium to high. As an example, Auerbach J et al., 
(2015) noted that most women at risk of HIV were not told about PrEP from their 
primary doctors and OB-GYNs whom they have a close patient-doctor relationship 
with. The community staff are recommended to be trained about PrEP to improve their 
competency regarding the topic (Sybil G. Hosek, 2013). Rowniak S, 2015 also 
mentioned that PrEP was a new concept to many healthcare practitioners in the US. [1, 
5, 6, 7, 8].  
PrEP uptake: Because of low knowledge about PrEP from both patients and the HCPs, 
the uptake of PrEP is also low. As proven by Haire BG, 2015, most of PrEP 
consumption 3 years after FDA approval was through demonstration website or 
research purposes. [1, 3, 5, 7, 8, 9]. 
PrEP demand: Despite all that, demand for PrEP from the patients has been documented 
to be high. Female patients in the high risk of HIV groups were voicing their opinions to 
demand PrEP to be available for them, such groups are, namely sex workers, drug-
users, serodiscordant couples, black women (Auerbach J et al., 2015). [1, 3, 9]. 
7.3 Challenges faced by patients 
A critical subtheme worth mentioning is the aspect of challenges associated with PrEP. 
Firstly, challenges faced by the patients are discussed before challenges faced by HCPs.  
Cost: cost is a major challenge that PrEP users face, in which it depends on their 
demographic and geographic circumstances. Despite HIV being an epidemic for those 
most vulnerable to HIV infection, PrEP in the US is only accessible depending on one´s 
insurance scheme (Auerbach J et al., 2015). For those in the high-risk groups like 
transgender, sex workers, MSM, etc., accessing PrEP through the government scheme 
can be an option, but it is also limited. For example, transgender women are 
 31 
 
documented to benefit from PrEP on an individual level. However, on a large public 
scale, it is still vague whether PrEP is cost-effective for this group which would make it 
harder for them to access PrEP through a public scheme (Poteat T et al., 2015). The 
same scenario is considered in serodiscordant heterosexual couples, IDU, whether PrEP 
would be cost-effective on a larger scale (McMahon J et al., 2014; Alistar S et al., 
2014). However, cheaper generic version of PrEP will be available in the future when 
the patent runs out (McMahon J et al., 2014). [1, 2, 3, 4]. 
Long-term effect: The possible long-term effect of PrEP is a significant concern to be 
faced by the patients. The combination of PrEP and certain progesterone-based 
hormonal contraceptives were found to deliver possible exacerbation of bone loss and 
fractures in women. Older age can have an impact on continuous PrEP usages such as 
renal toxicity and bone loss (McMahon J et al., 2014). However, Rowniak S (2015) 
stated that the long-term side effects for those with specific diseases are unknown. [3, 
6].  
Peer influence: Peer influence manifests itself as much of a challenge faced by many 
patients. PrEP uptake could be mitigated against due to negative reaction from peers, 
friends, and family (Haire BG, 2015). [3, 9]. 
Mistrust: Patient´s mistrust in the healthcare establishments, healthcare professionals 
and the drug itself is also a hurdle to PrEP uptake (Auerbach J et al., 2015; Haire BG, 
2015). In the interview, some women voiced their concerns about being ´guinea pigs´ 
for PrEP. They often misunderstand that PrEP is a new drug when in fact the drug itself 
has been around for many years for HIV treatment. What is new is the approval of the 
drug for HIV prevention (Haire BG, 2015). [1, 9].  
Stigma: One great hurdle impacting the uptake of PrEP is the stigma associated with the 
medicine and the person taking it. Firstly, the person taking it might be misperceived as 
HIV positive by their partners (Auerbach J et al., 2015). This is especially transgender 
women who face a lot of stigma in the clinical settings as well as in their social life 
which could also impact on PrEP uptake in this group (Poteat T et al., 2015). Secondly, 
the person taking PrEP can also be stigmatised to have sexual risk-taking behaviours 
such as being homosexual, being promiscuous, sex work, inconsistent with condom 
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usage, sex out of relationship and IDU. In the gay community, PrEP takers can be 
branded as ´Truvada whore´ which can sound derogatory (Haire BG, 2015). [1, 2, 3, 9].  
Side effects: Despite being an approved drug, PrEP can still have possible side effects 
which vary from person to person. These possible side effects act as precursors to the 
obstacle of PrEP uptake. Short term possible side effects are diarrhea, vomiting, nausea, 
renal problems, such as drug-drug interaction. Therefore, side effect monitoring is 
necessary (Auerbach J et al., 2015; McMahon J et al., 2014; Rowniak S, 2015). [1, 3, 6].  
Adherence: Adherence is the biggest obstacle faced by the patients when taking PrEP. 
All of the stigmas mentioned above are catalysts to obstacles of adherence to PrEP. For 
example, the PrEP user would find it hard to take a pill daily if they are scared of their 
partner mistaking them for being HIV positive (Auerbach J et al., 2015). The stigma of 
being labeled as someone having high risk-taking behaviors, being called “Truvada 
whore”, has a negative impact on adherence. Lower drug adherence is found in Black 
and mixed-race men. The stigma of being branded homosexual can also impact 
adherence (Haire BG, 2015). However, the case is reversed in serodiscordant couples 
when the HIV negative partner is supported by their positive partner to adhere to the 
daily regime (McMahon J et al., 2014). It was found that poor adherence is linked to no 
reduction in risk of HIV acquisition (Alistar S et al., 2014). From the HCPs´ point of 
view, lack of confidence in adherence from the patients also plays a major role in the 
reluctance of prescribing the medication (Krakower DS & Mayer KH, 2016). Follow-up 
can be a great challenge faced by many patients when taking PrEP. Personal 
circumstances like poverty, mental health, substance abuse and homelessness can hinder 
a patient from coming to follow-up medical appointment, testing and monitoring of 
PrEP (Haire BG, 2015). [1, 3, 4, 7, 9].  
7.4 Challenges faced by HCPs 
Secondly, the challenges derived from PrEP that the HCPs face play an essential role in 
PrEP uptake.  
Drug resistance: Many HCPs express the fear of drug resistance. Many patients in the 
acute phase of HIV do not know that they are being infected. If PrEP is used in the 
acute phase of HIV, it could potentially lead to ARV-resistance HIV strain (McMahon J 
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et al., 2014). HIV seroconverting of acute HIV phase is likely to be higher in those who 
do not adhere to the daily dosage, and as mentioned above, adherence is one of the 
biggest challenges in PrEP uptake. Therefore, it is recommended PrEP users get HIV 
test every three months to rule out the case of seroconverting. However, adhering to the 
follow-up tests is not always abided by, by the patients due to personal circumstances 
(Rowniak S, 2015). The fear of resistant viral strains acts as a precursor to reluctance to 
prescribe PrEP (Krakower DS & Mayer KH, 2016). [3, 6, 7].  
Risk compensation: The next major challenge of PrEP faced by HCPs is the fear of risk 
compensation. PrEP could lead to decrease in use of condoms which acts as a precursor 
to a potentially higher risk of STIs including HIV (Haire BG, 2015). McMahon J et al., 
(2014) noted that PrEP encourages behavioral risk compensation when the rate of 
condom use is compromised in serodiscordant couples. In fact, many MSM admit 
openly that they are not planning to use condoms when they are on PrEP (Rowniak S, 
2015). Despite the fact that there is no clear data suggesting evidence of PrEP leading to 
higher risk of HIV and STIs acquisition, risk compensation is still a concern expressed 
by many HCPs (Krakower DS & Mayer KH, 2016; Haire BG, 2015). Unconscious bias 
attitude from HCPs was found in another study regarding racial stereotype of the 
patient. The study showed that PrEP was less willing to be prescribed for HIV negative 
black partner in HIV discordant couples due to the perceived ´increased´ unprotected 
sex which could lead to risk compensation risk (Haire BG, 2015). [3, 6, 7, 9]. 
Attitude: The attitude of the HCPs is also a contributing factor to the reluctance of PrEP 
prescription leading to low PrEP uptake. In a study done by McMahon J et al., 2014, 
many surveyed HCPs mentioned that PrEP is out of their scope of practice because they 
only treat HIV positive patients. Another attitude documented in many HCPs is their 
lack of confidence in real-world effectiveness and patient adherence as well as feeling 
inadequate to prescribe PrEP for IUDs (Krakower DS & Mayer KH, 2016). [3, 7]. 
Guidance: Despite FDA approval as well as endorsement by the CDC and WHO, some 
countries still lack local guidance that hinders local HCPs from prescribing and 
providing PrEP. For example, there is a lack of local guidelines regarding PrEP outside 
of the U.S. However, it is predicted that many countries will issue guidelines in the 
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future (Krakower DS & Mayer KH, 2016). Moreover, some HCPs think of CDC´s 
guidelines as being ambiguous (Haire BG, 2015). [7, 9]. 
7.5 Recommendations for HCPs 
Information delivery and patient education: In the study of Auerbach J et al., (2015), 
interviewed patients thought that sufficient information about PrEP should be provided 
to those with a need for it. In other words, HCPs ought to be responsible for being the 
information gateway between PrEP and patients in need. Patients have the right to know 
about PrEP and its relevant information. For example, HCPs should make it clear to 
patients that PrEP is not a new, drug; it is only newly approved as an HIV prevention 
method. McMahon J et al., (2014) stated that discordant couples are ideally served at 
primary care, family planning and STD clinics where the settings are fit to serve, 
delivery information and treatment planning, as well as provision of PrEP, are carried 
out. Communication and engagement with the PrEP users and their HIV-positive 
partners are key to success. [1, 3, 5, 6, 8, 9, 10]. 
Build a trusting relationship with the patients: HCPs can deliver the information 
efficiently as well as increase the uptake of PrEP for women in need by building 
trusting relationships with the patients. For example, enough time needs to be given for 
the session to be able to talk about not just PrEP but sexual health in general (Auerbach 
J et al., 2015). [1]. 
Community empowerment: It was found that effective HIV prevention and intervention 
for TSW comes from community empowerment, supportive network and health services 
with emphases on mental and behavioral culture (Poteat T et al., 2015). It was 
evidenced that HIV prevention strategies are extremely effective when carried out in 
non-clinical settings at community levels. Therefore, CBOs play a critical role in 
educating and engaging the targeted high-risk groups for HIV. The staff can achieve this 
by receiving sufficient training and education about PrEP to deliver accurate and trusted 
information regarding HIV prevention. Opinion leaders are a key information gateway 
(Sybil G. Hosek, 2013). The issue is raised when most of HIV prevention efforts and 
outcomes in the US are implemented and achieved by HIV CBOs. However, CBOs are 
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often disadvantaged in the infrastructure department to identify, engage and provide 
ongoing care for PrEP users and its candidates (Eaton L et al., 2015). [2, 5, 8].  
Adherence and follow-up support: According to the trials´ results, adherence and 
adherence support is the key factor contributing to the effectiveness of PrEP (Alistar S 
et al., 2014). Every 3-month follow-up should be carried out with PrEP users which 
include HIV and STI testing as well as counseling about adherence (Rowniak S, 2015). 
Marcus J, et at. (2014) reviewed various adherence support methods that an HCP could 
use for PrEP users. First of all, the patients should be educated about the importance of 
adherence in taking the daily dosage. Different recommendations for higher adherence 
rate could be incorporating pill-taking into the daily routine like eating, brushing teeth, 
waking up or going to sleep. However, remembering daily dosage can be challenging 
when traveling so developing skills to remember should also be included in counseling. 
Phone calls to check up on adherence and follow-up visits were found to be effective. 
Printed materials and discussion about the medication that includes risk of infection, 
adherence, side effects and signs of acute HIV infection should be provided by HCPs. 
Possible effective methods to promote PrEP adherence that were demonstrated in some 
projects are handouts about PrEP information and adherence guidance, phone calls and 
SMS to promote adherence, drug concentration feedback as well as adherence 
counseling. [4, 6, 10].  
Risk evaluation: It is evidenced that many individuals at high risk of HIV are not aware 
of PrEP. Thus, HCPs such as nurses ought to be the gatekeepers of PrEP for high-risk 
individuals. It is our job to set criteria to identify individuals at risk who would benefit 
from PrEP (Rowniak S, 2015). HCPs are suggested to reach out and recommend PrEP 
to the most at-risk groups. They do not just have to consider the health benefits of the 
patients but also to assign resources in the most cost-effective way. For example, public 
HCPs are recommended to target PrEP to IDUs at high risk for HIV instead of IDUs 
with low risk due to cost-effective budgeting. If PrEP, MMT and ART programs can 
cater the high-risk IDU groups that are involved in needle and sexual sharing, the 
outcome and cost will be estimated to be very effective (Alistar S et al., 2014). HCPs 
need to receive adequate training about HIV risk evaluation. Healthcare professionals 
should be given the right resources like time for in-depth conversation with the patients. 
Using a ready risk prediction tool that is computer-based is recommended (Krakower 
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DS & Mayer KH, 2016). CBOs at non-clinical settings were documented to have 
repeatedly encountered individuals at high risk for HIV, who usually do not seek for 
testing and help from conventional clinical settings. Hence, it is observed that CBOs are 
at an ideal position to introduce PrEP to these high-risk individuals (Sybil G. Hosek, 
2013). [4, 5, 6, 7].  
Social justice: Since follow-up appointments are part of the official PrEP regime and 
guidelines, those who can keep up with this are often favored by HCPs. However, 
should those who cannot keep up with follow-up appointments be given a chance with 
PrEP considering PrEP could be a life changer for many? Social justice principles 
should be considered by HCPs. Moreover, the cost of PrEP can be covered for those 
who have proper insurance which leaves many individuals with no appropriate 
coverage, out of the equation. For this reason, nurses are recommended to exercise 
social justice principles on those marginalised and stigmatised in society since many of 
them are the ones most at risk (Rowniak S, 2015). There is also a hypothesis that many 
HCPs think PrEP takers are taking resources away from HIV-positive people. It was 
found that HCPs have racial biases when making decision to prescribe PrEP for certain 
racial minorities. By acknowledging this, HCPs can make more socially justified 
decisions when providing PrEP (Krakower DS & Mayer KH, 2016). [6, 7].  
PrEP education for HCPs: It is observed that services provided by HIV/AIDS medical 
providers could have been improved if primary care providers received training about 
PrEP such as sexual health assessment and CDC guidelines (Eaton L et al., 2015). HCPs 
ought to receive adequate training and education about PrEP, risk assessment like 
patient interview, sexual health training, using risk predictor tools, etc. (Krakower DS & 
Mayer KH, 2016). [7, 8].  
HIV testing and PrEP: As mentioned above, drug resistance poses a fear faced by many 
HCPs when providing PrEP. Therefore, the only way to combat drug ART drug 
resistance is providing quarterly HIV testing for PrEP takers according to the CDC´s 
guidelines. However, frequent HIV testing remains a challenge for many patients and 
HCPs (McMahon J et al., 2014; Sybil G. Hosek, 2013). CBOs at non-clinical settings 
can also carry out HIV testing for high-risk individuals to share the burden with 
traditional clinical settings (Sybil G. Hosek, 2013). It is also recommended that HCPs 
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talk about PrEP with high-risk individuals at HIV testing and counseling (Eaton L et al., 
2015). HCPs should recommend to the patients the FDA approved method of home-
based rapid HIV self-testing, which was found to have a positive impact on PrEP 
adherence (Marcus J, et at., 2014). [3, 5, 8, 10].  
All minor and major categories formulate into 3 sub-themes which are Risk assessment 
& needs, Challenges and Recommendation for HCPS. 3 sub-themes contribute to 
making the theme PrEP in HIV prevention and the role of HCPs.  
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8 DISCUSSION 
According to the findings of the 10 articles, it is evidenced that PrEP plays an important 
role in HIV preventive methods for those at high risk. The groups prone to HIV that 
might benefit from PrEP includes MSM, black MSM, women, Back and Latina women, 
IDUs, discordant couples and transgender. Those with high-risk behaviors such as 
frequent change of partners, needle sharing, sex workers and people who do not use 
condoms for sex would also benefit from PrEP. Despite PrEP being approved by the 
FDA, recommended by CDC and WHO, there are still many challenges faced by the 
patients and HCPs in the uptake of PrEP. Cost, adherence, and stigma greatly hinder 
patients from starting and maintaining PrEP uptake. Drug resistance and risk 
compensation are most feared by many HCPs when prescribing PrEP. 4 out of 10 
articles (3, 6, 8, 10) have content of nursing elements. However, all 10 articles give 
recommendations to HCPs in general in which nurses are also included in the HCPs 
group. Therefore, discussion about recommendations for a nurses´ role will be similar to 
the recommendations for HCPs found in all 10 articles as long as these 
recommendations are within the scope of nurses´ roles and duties. Given the needs as 
well as the obstacles relevant to PrEP, nurses, they are recommended to evaluate and 
identify individuals at most risk of HIV, provide and educate them with accurate 
information about PrEP, support adherence and follow-up appointments as well as 
integrate PrEP into HIV testing. Table 5 appendix 4 delves into how each article 
answers the author´s 3 research questions.  
8.1 Risk & needs assessment: implying nurse´s role through 
HIV prevention model  
According to the HIV prevention model, HIV risk & needs assessment should only be 
performed when an individual is tested negative for HIV. An evidence-based HIV 
prevention method like PrEP should be considered for those at high risk. Following a 
test result, nurses, as well as other HCPs, are recommended to identify patients who 
belong to the high-risk groups. According to the results of this study, MSM and black 
MSM have the highest rate of HIV infection compared to other high-risk groups. These 
are followed by transgender, IDUs, women including Black and Latina women. In real 
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life situations, the statistics may differ depending on geographical locations. Besides 
identifying the race and gender at high risk for HIV, nurses should also identify patients 
that have high-risk behaviors like sex work, needle sharing, in a discordant relationship, 
practice sex without condoms, and frequent change of partners. It is suggested that the 
nurse should engage with the patients by building a trusting relationship by allowing 
enough time for open communication in the counseling session. Risk assessment should 
also be based on evidence-based CDC guidelines. For instance, when identifying sexual 
risk for HIV acquisition, it is very important to obtain an overall picture by asking 
questions. The CDC has already published sample questions to ask both MSM and 
heterosexual men & women. Such question would reveal roughly how many sexual 
partners the patients have, genders of the sexual partners, HIV status of the sexual 
partners, whether condoms are used during penetrative sex and whether the sex involves 
anal intercourse. The nurse might also want to obtain information about past STIs 
infection that the patients have such as chlamydia, syphilis, and gonorrhea because STIs 
increase the chance of acquiring HIV. Most importantly, the nurse should be familiar 
with sexual practices that put the patients at higher risk of HIV like sex without 
condoms anal sex, substance abuse, drug injection and needle sharing. Inconsistent use 
of condoms in casual sex is also a red flag for HIV risk (CDC, 2014c). Nurses should 
keep in mind that patients in a committed monogamous relationship are not subjected to 
zero risks of HIV acquisition. In fact, according to the results of this study, McMahon J, 
et al., (2014) noted that Latin women in California with primary partners were at higher 
risk of HIV compared to those with non-primary partners. This might sound 
contradictory to many but the author hypothesises that men can have unprotected sex 
outside of the main relationship which puts many women at risk of HIV and other STIs. 
In reality, this phenomenon has been self-depicted by a Youtuber called Jennifer 
Vaughan who publishes videos about her life living with HIV and how she acquired it. 
In one of her videos, she told that she acquired the virus through her ex whom she 
thought was monogamous with her (Jennifer Vaughan, 2017). Once the evidence is 
clearly assessed that patient is at high risk of HIV, PrEP and condoms are both 
recommended. Krakower DS & Mayer KH, (2016) suggests HCPs be educated and 
trained on how to assess patients for HIV risk who can be candidates for PrEP. The 
study also recommends a prediction tool on a computer tablet for standardised HIV risk 
assessment. Patient´s electronic health record is also a good start to screen for HIV risk. 
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At this point, the nurse should work together with the physicians to provide accurate 
and evidence-based information about PrEP such as how the drug works, possible side 
effects, how effective the drug is, adherence and follow-up requirement while on PrEP. 
It is very important for the patients to understand that PrEP is not a substitute for 
condoms but rather an additional protective tool in the case of condom failure or 
situations when condoms are not an option like drug injection. Moreover, nurses should 
explain to the patients that PrEP only protects against HIV, which means that they 
would still be prone to STIs without protection from condoms. The result of this study 
also revealed that many patients would not use condoms even before and after knowing 
about PrEP. Despite being an additional tool, PrEP is still more than 95% effective 
when used with consistent adherence. Many people have developed a non-fatalistic 
attitude towards HIV thinking that the virus can now be managed. This can lead to 
complacency. For people who refuse to use condoms, it is plausible to think that 
protection from PrEP is better than no protection. 
8.2 Challenges: implying nurse´s role through HIV prevention 
model  
Once the risk and need for PrEP is identified. The first challenge to mention is the cost 
of accessing the medicine. Access and prices of PrEP differ depending on the 
geographical locations. In the US, most PrEP takers are properly insured. The HIV 
prevention model recommends that the patients should be provided with linkage to 
prevention services. The scope of this study does not delve into how insurance for PrEP 
coverage in the US works and how to get access to PrEP by any other means. The rules 
and regulations are different in different countries and regions. The borderline can be 
thin between marketing for the drug and helping patients. Marketing and selling drugs is 
definitely not included in the scope of a nurses´ role and therefore, the topic of access to 
PrEP is not discussed in depth here. However, besides connecting patients with STI 
clinics and services, nurses can generally link the patients to different suitable insurance 
that covers PrEP. If insurance is not an option, there are some equality programs like 
´Truvada for PrEP medication assistance program´ that aid patients in financing PrEP´s 
cost (Gilead, Truvada for PrEP medication assistance program). As mentioned in the 
results, public HCPs have to consider the aspect of cost-effectiveness when providing 
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PrEP for free. The general rule is that it is more cost effective if PrEP is introduced to 
those at higher risk of HIV. In other words, nurses could jeopardize the cost-
effectiveness if patients who are not at high risk for HIV, are told about PrEP. This 
leads to an ethical dilemma whether to provide PrEP and information about PrEP to 
those with little to medium risk of HIV, who would still benefit from PrEP if the 
medication was provided for free through National Health Service. It is hypothesized 
that resources for the medicine are finite for regions that provide PrEP for free, which is 
one of the reasons to explain why uptake for PrEP is low in contrast to high demand for 
the drug. Many HCPs argue that an antiretroviral drug for PrEP is taking away 
resources from HIV-positive individuals. Despite the complex laws and regulations, 
nurses are to follow the local guidelines. Furthermore, the results of the study manifest 
that nurses should exercise the principle of social justice by helping those minority 
groups who are usually mistreated by the healthcare system. This can be done by 
linking them to CBOs where they can get helped with PrEP cost as well as mental and 
social support.  
As for now, according to prepwatch, PrEP is only officially available in places which, to 
name a few, are Australia, Belgium, Canada, France, Germany, Netherlands, Norway, 
United Kingdom, United States, etc. Finland has yet to approve the use of Tenofovir 
and Emtricitabine drug as PrEP and there is yet to be any national law and guidelines 
regarding this topic. Nevertheless, it is probable that Finland would follow the Nordic 
neighbor Norway in approving and providing PrEP for free to those at high risk of HIV 
acquisition. Nurses from Finland could find this study helpful when the country 
approves PrEP. In Europe, PrEP is offered for free through National Health Service in 
France, Belgium, Scotland and Norway (PrEP in Europe). However, it is known that 
many people have found their way around buying PrEP unofficially because they live in 
countries where access to PrEP is not easy. According to the scope of this study, the 
author does not go into any depth about PrEP access and the danger as well as benefits 
of unofficial PrEP purchases. The laws for accessing the medication are country-
specific and that is speculated to change over time.  
Engagement, retention and adherence is a part of the HIV prevention model. This part 
of the process can be implemented through nursing intervention. The process can be 
obstructed by the challenges that the patients face like mistrust in the healthcare system, 
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adherence, peer influence, and stigma. As mentioned above, building a trusting 
relationship with the patients through communication is evidenced in disputing 
mistrustful attitude. Nurses ought to self-educate about the topic of PrEP in order to 
provide the patients with accurate information. CBOs can be an environment for the 
patients to connect with other patients with the help of CBO staffs and community 
nurses. Behavioral social intervention offered by CBOs play an essential role in 
relieving stigmas and negative peer influence about PrEP and PrEP takers. Nurses are 
recommended to provide feedback, counseling, mental health services for the patients 
for maximum adherence rate. SMS and phone calls for PrEP adherence reminder were 
found to be effective in helping the patients taking sufficient doses.   
The struggle to adhere to follow-up appointments while on PrEP was demonstrated in 
the results of this study. In accordance with the HIV prevention model, HIV testing and 
re-testing remains a critical point in which serves the purpose of follow-up 
appointments. Patients with personal circumstances like poverty and mental health were 
found to neglect their responsibility to keep up with follow-up appointments. Nurses 
can cooperate with social workers to help these patients with their personal 
circumstances. At the initial point of HIV testing, HIV negative individuals who are at 
high risk of HIV should be told about PrEP. The decision to go on PrEP or not will 
depend on the autonomous choice that the individual makes, nurses and other HCPs are 
only information gatekeepers at this point. By the time of the PrEP follow-up 
appointment, HIV testing plays a crucial role in determining whether PrEP is still 
suitable. If the person is found to be seroconverting, a plan for HIV treatment is to be 
considered. Thus, HIV testing and retesting is a gateway between HIV prevention and 
HIV treatment.  
Another fear about PrEP faced by the HCPs is risk compensation. In the results, it was 
found that many HCPs are reluctant in providing PrEP thinking that condom use would 
be compensated in PrEP takers and that STIs rate would be increased. However, there 
was speculation in Australia stating that PrEP reduces STI rate. Doctor Roth, a sexual 
health doctor in Melbourne explained that quarterly routine HIV and STI check-ups for 
PrEP takers are a lot more often compared to those who are not using PrEP. Therefore, 
STIs would be detected and treated early enough before it is passed on (Emily Woods 
 43 
 
and Rania Spooner, 2017). Nurses and other HCPs might be more convinced and 
assured about the benefits of PrEP knowing this fact.   
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9 CONCLUSION AND CRITICAL DISCUSSION 
The findings of the research have answered the three proposed research questions 
(Appendix 4 table 5) and the discussion section made sense of the relationship between 
the findings, research questions, and the theoretical framework.  
Firstly, thorough information about PrEP was included in the background as well as the 
findings. To emphasize the role PrEP plays in HIV prevention, facts about HIV risks 
categorized in gender, sexuality, race and risky behaviors were included in the findings. 
In response to question 1, the findings provided sufficient evidence that PrEP is 
beneficial for those at high risk of HIV acquisition. In the discussion section, the role of 
the nurse regarding providing care of PrEP is recommended according to the findings 
and the theoretical framework. In this case, nurses are suggested to provide needs and 
risk assessment for the patients following a negative HIV test result.  
Secondly, after the challenges faced by the patients and the HCPs are identified from 
the findings, possible measures to combat these barriers were presented in the findings 
as well as the discussion sections. It was discussed that the recommendations for HCPs 
were linked with the theoretical framework and nursing roles. For example, in order to 
provide linkage to prevention services, nurses can introduce high-risk patients to 
healthcare facilities that provide sexual health services like STI testing, PrEP and 
condom provision. Moreover, other communities to be recommended are those that 
advocate and support the patients like the LGBT community, sex-worker community, 
drug rehabilitation programme, etc. Lastly, the findings showed that there is much 
nurses can do to retain and engage the patient as well as help them adhere to the 
recommended PrEP dosage in conjunction with other prevention methods, as suggested 
in the theoretical framework. It is crucial to build a trusting relationship with the 
patients as many may have lost faith in the healthcare system. In order to achieve such 
goal, nurses ought to educate themselves about the facts of PrEP to provide reliable 
sources of information to the patients. Other documented effective measures to boost 
the rate of PrEP adherence is providing counseling, feedback, phone calls and SMS 
reminder.  
 
As mentioned in the discussion section, the regulations regarding PrEP is regionally 
specific. PrEP may be subsidized by the national healthcare in some countries but not in 
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others. For example, those vulnerable to HIV can already access PrEP for free in 
Norway but not yet in Finland. Having said that, it is hypothesized that regulations 
regarding PrEP can be subjected to change in response to the prevalence of new 
infections and high demand for the drug as mentioned in one of the findings.  
 
Credibility, dependability, and transferability are the three elements used to measure the 
level of trustworthiness of a research study whether it´s qualitative or quantitative. As 
for evaluating the quality of the thesis, the findings are to be scrutinized in the process 
of which those findings were derived from. Graneheim & lundman (2004) 
 
To evaluate whether a research study is credible, one would have to look at its data and 
assess to what degree the data and its process is confident in the scope of focus of the 
study. Olivia from StatisticsSolutions argues that the researcher needs to draw a link 
between the study´s findings and the reality to shed light on the truth of the findings. 
She also suggested the triangulation methods to strengthen one´s research. This research 
study implements the method of triangulation of sources for this purpose. The findings 
were derived from different data sources (as seen in the table of data collection) to fetch 
for articles using inclusion and exclusion criteria. This ensures that the chosen articles 
can provide data greatly relevant to the research questions and serve the aim of the 
study. Moreover, the author incorporated a diversity of genders and sexuality (MSM, 
transgender, heterosexual) on the topic of oral PrEP and HIV prevention.  
 
The trustworthiness of research study also relies on to what extent the data depends on 
factors of instability and factors of phenomenological changes. Since PrEP was only 
approved by the FDA in 2012, all articles were filtered for from 2012 and onwards and 
only the most recent and relevant ones were chosen. This somewhat deflects the time 
impact of factors of instability on the integrity of the data. In addition, WebMD (2016) 
noted that HIV and its treatment were discovered in 1981 and 1996 respectively, the 
approval of oral PrEP in 2012 is still arguably considered a new phenomenon that many 
people are not aware of. The significance of PrEP is hypothesized to be subject to 
changes in the future may it be new drugs for pre-exposure prophylaxis, the approval of 
microbicides or even a breakthrough in HIV vaccine. It is uncertain if more failure cases 
of PrEP would occur due to resistant virus besides the 3 existing ones represented in the 
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background of this study. Any innovations or changes in the field of HIV prevention 
can place this research study out of reality´s relevance. For instance, if a vaccine for 
HIV is successfully made in the future, PrEP could become a thing of the past and this 
research study may become dated. Having said that, it is important for nurses and other 
medical professionals to keep track and self-educate about new evidence-based 
innovations as well as changes regarding this field. As for the date of this study, the 
phenomenon of PrEP is relevant as proven in the section “information about PrEP” in 
the findings.  
 
In the light of transferability, as seen in the section of methodology, the author tried to 
explain as clearly as possible the processes of unit selection, data collection, and 
analysis processes. The study can only be as trustworthy as its data being able to be 
replicated in other studies of different contexts using a transparent process. 
9.1 Limitations and recommendations 
There are two major limitations of this dissertation. Firstly, only half of the research 
model is used. As stated in the theoretical framework section that the scope of the study 
only focuses on HIV negative patients who are at high risks. The other half of the 
research model is for patients who have already been found to be infected with HIV and 
that TasP can be used to prevent them from spreading the virus to others in the early 
stage of the infection. However, the whole model should be investigated in further 
research because only the linkage between primary and secondary HIV prevention can 
provide a big and complete picture of effective prevention process. Secondly, the scope 
of this study is limited in the biomedical approach of HIV prevention which excludes 
behavioral and structural approaches. Further investigation to interlink all three 
intervention approaches for nursing roles in HIV prevention should be carried out. One 
may find more limitations to the thesis besides the major 2 mentioned here. In summary, 
because the topic of HIV prevention is broad, further nursing research should be carried 
out to fill the academic gap in response to innovation and changes in this field.  
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Appendix 1 
 
Figure 2 Comprehensive HIV prevention processes by Horn T et al. (2016) 
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Appendix 2 
Table 3 An example of inductive qualitative content analysis of PrEP in HIV prevention and the roles of HCPs: Eaton 
L, et al., 2015, Minimal Awareness and Stalled Uptake of Pre-Exposure Prophylaxis (PrEP) Among at Risk, HIV-
Negative, Black Men Who Have Sex with Men 
Meaning unit Condensed 
meaning unit, 
using the words 
from text 
Condensed 
meaning 
unit´s latent 
meaning  
Codes Categories  
In the USA, men who have sex with men 
(MSM) account for 48% of people living 
with HIV and 53% of incident HIV 
infections; however, they comprise only 
about 3% of the male population. As such, 
the rate of HIV diagnosis among MSM is 
44 times that of other men 
Research has 
shown that MSM 
are in the group of 
high prevalence of 
HIV  
MSM are at 
high risk of 
HIV 
Gender and 
sexuality  
 
HIV risk 
 
Black MSM (BMSM) in particular are the 
most affected by HIV in the United States. 
BMSM are diagnosed with HIV at a rate 
6.0 times higher than white MSM and are 
3.8 times more likely to be living with HIV 
than white MSM 
Black MSM is 
shown to be in the 
group of highest 
HIV prevalence in 
the USA 
Black MSM 
are at high risk 
of HIV 
Race 
 
In addition to HIV testing, engaging in 
transactional sex was associated with being 
unaware of PrEP in our multivariate model. 
Given the power imbalance that exists for 
negotiating safer sex practices during 
transactional sex, it is likely that these men 
are at elevated risk for HIV transmission 
compared with men not engaging in these 
behaviors. 
Men who engage 
in sex work have 
less negotiating 
power in safer sex 
practices 
Sex workers 
are at high risk 
of HIV 
Risky behavior 
Pre-exposure prophylaxis (PrEP) strategy 
holds tremendous promise, yet our ability to 
implement a wide-spread, scale-up of PrEP 
for those at-risk for exposure to HIV in the 
US has been slow 
There is a gap 
between number 
of people at risk 
and those who 
know about PrEP 
PrEP are not 
known to the 
many of those 
at risk in the 
US.  
PrEP knowledge 
from patients 
Information 
about PrEP 
 
 
 
Black MSM awareness is still low after 
FDA approval 
Low level of 
awareness about 
PrEP from BMSM 
BSMS – low 
PrEP 
awareness 
PrEP knowledge 
from patients 
Namely, PrEP was approved by the US 
Food and Drug Administration (FDA) in 
July 2012, and as of March 2013, an 
estimate of 1774 people in the US have 
been prescribed the drug, with 48% of those 
Huge gap between 
new infections and 
people on PrEP 
that needs to be 
addressed 
People at high 
risk are not 
prescribed 
PrEP 
PrEP low uptake 
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prescriptions being written for women. 
However, with 50,000 annual HIV 
infections, scale-up of PrEP will necessitate 
greater population uptake than what we 
currently observe 
 
Although improvements have been made in 
biomedical HIV prevention tools, these 
advances do not help improve the lives of 
those at-risk for HIV if they are not 
disseminated and readily accessible 
Information about 
new HIV 
prevention 
methods are not 
spread, hence lives 
are still at-risk 
Healthcare 
providers do 
not provide 
information 
about PrEP 
PrEP knowledge 
from healthcare 
providers 
Public health agencies must evaluate their 
current approaches to PrEP, as without 
considerable changes in the current status 
quo, PrEP may remain largely 
underutilized. Public health agencies and 
primary care providers need to develop 
stronger ties in order to identify and link to 
ongoing care individuals who are at 
elevated risk for HIV. We must now 
prioritize working towards reducing 
barriers to accessing care for HIV negative 
men and developing novel ways to reach 
and engage men who are unaware of 
prevention services. 
Patients at high 
risk need to be 
identified and 
given information 
about PrEP from 
local healthcare 
providers  
Healthcare 
providers need 
to inform high-
risk individuals 
about PrEP 
Information 
delivery, patient 
education 
Recommendation 
for HCPs 
   
 
Although historically much of the HIV 
prevention and treatment efforts in the US 
have been carried out by community-based 
HIV/ AIDS organizations, many of these 
agencies are likely unequipped within their 
currently existing infrastructure to not only 
raise awareness of PrEP, but seek out, 
engage, and provide ongoing care for 
individuals who are on PrEP or candidates 
for PrEP 
Promoting PrEP 
needs effort from 
healthcare workers 
in the community 
 
Healthcare 
workers are at 
perfect 
position to 
promote PrEP 
in local 
community 
Community 
empowerment 
 
Open the need to either enhance and 
improve services provided by HIV/AIDS 
medical providers, or to train primary care 
providers in sexual health assessments and 
CDC guidelines on PrEP use, and 
invigorate efforts to promote PrEP 
Healthcare 
workers need 
training about 
PrEP 
PrEP education 
for healthcare 
workers 
PrEP education for 
nurses 
Having an awareness of PrEP is also linked 
to greater connection with an understanding 
of HIV prevention services. These ﬁndings 
Healthcare 
providers need to 
talk to high-risks 
High-risk 
patients should 
be informed 
HIV testing and 
PrEP 
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underscore the importance of integrating 
conversations about PrEP within HIV test 
counseling. 
patients about 
PrEP at HIV 
testing 
about PrEP 
during HIV 
testing 
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Appendix 3 
Table 4 Formulation of major and minor categories of 10 unit of analysis 
Article 
Number 
Categorised condensed meaning units in accordance with Graneheim and Lundman (2004)  
(Names of the categories are in underlined characters)  
1 HIV risk: Heterosexual, Black and young women are at high risk of contracting HIV. 
Information about PrEP: PrEP to prevent HIV transmission is approved by the FDA. However, the knowledge and awareness of 
PrEP among patients and healthcare providers are still low. The demand for PrEP is higher than supply while uptake is still low.  
Challenge: usage of PrEP is faced by the patients with various challenges namely costs, side-effects, mistrust in the system, stigma 
as well as adherence.  
HCPs´ role: Nurses should spread accurate information about PrEP to high-risk patients while building trust with the patients.  
2 HIV risk: Transgender are at higher risk of HIV due to biological, psychological and environmental factors. Sex work in transgender 
is also a risky behavior.  
Information about PrEP: the argument of PrEP being beneficial in the large scale in the transgender community is still debatable.  
Challenge: faced by the patients - Transgender faces high stigma and discrimination. They also have a harder time accessing 
medical aids like insurance issues. Faced by healthcare providers - Public health is still considering if it is cost-effective to 
recommend PrEP to the trans community which poses a moral issue. 
HCPs´ role: Nurses need to recommend condoms, PrEP, stable partners as well as HIV treatment for positives partners. Nurses 
should connect trans patients to the community and appropriate medical services.   
3 HIV risk: HIV negative partners with serodiscordant heterosexual couples are at high risk for HIV. African and Latino women are at 
higher risk of HIV. Transmission is higher for women with a primary male partner.  
Information about PrEP: PrEP for HIV prevention is approved and recommended by the FDA and CDC. PrEP is proven to be 
effective to those who adhere to the medication. PrEP offers extra protection when ART fails 
Challenge: Faced by healthcare providers - Uptake for PrEP in this group is low due to the operating healthcare system. Other 
barriers are fear of drug resistance, adherence and decreased condom usage (risk compensation). Many healthcare providers only 
treat HIV positive patients. Faced by the patients: concerns about side effects, stigma and biological factors like renal diseases or 
taking nephrotoxic drugs. Higher acceptance and adherence is shown in HIV serodiscordant couples. Other personal barriers to 
poverty, mental health and homelessness also affect PrEP usage. Costs and coverage also play as big hindrance.  
HCPs´ role: provide information about PrEP in the clinical setting when treating the HIV positive partner.  
4 HIV risk: injection drug users are at high risk of HIV.  
Information about PrEP: PrEP for HIV prevention is recommended by the CDC for IDU when condoms and clean needles are not 
available.  
Challenge: faced by the patients – adherence is the key to effectiveness. Faced by healthcare providers – cost-effectiveness is 
still debatable in this group. Combination of MMT and PrEP is still a challenge.   
HCPs´ role: it is proposed to only recommend PrEP to IDUs at certain high risk of HIV like IDUs of risky sexual behaviors, needle 
sharing, and drug mixing. Nurses should be aware of the cooperation between MMT, PrEP and ART programs. The issue of cost- 
effectiveness makes nurses face a dilemma when the public budget does not allow them to recommend PrEP to every IDUs despite 
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the fact that PrEP might be of help to the patients.  
5 HIV risk: Men who have sex with men are at high risk of HIV.  
Information about PrEP: PrEP for HIV prevention is approved by the FDA. PrEP uptake is low. Knowledge of PrEP in the 
community remains minimum and community healthcare workers are not well trained regarding the topic.  
HCPs´ role: HIV testing, condom education, and risk reduction counseling. The role of community empowerment is emphasised, 
therefore community nurses play a big role in PrEP. Nurses need to receive education about PrEP. It is important for nurses to 
identify individuals at high risk for HIV. Behavioral intervention can be used such as maintaining the relationship with the patients 
and assisting them with adhering to the medicine as well as HIV and STIs testing. Referring the patients to safe space community 
like LGBTQ organisations where PrEP can be promoted for high-risk individuals.   
6 HIV risk: Use of needle stick or having unprotected condomless sex. MSM and young MSM of color are at higher risk of HIV.  
Information about PrEP: FDA approved PrEP use for HIV prevention. Low knowledge of PrEP for healthcare providers 
Challenge: Faced by the patients: PrEP has short-term side effects. Long-time side effects are unknown. Cost: Many individuals 
are not covered by insurance or their insurance doesn´t cover PrEP. Faced by healthcare providers: behavioral changes when on 
PrEP, patients feel invincible to HIV. Risk compensation when condom usage decreases that leads to a rise in STDs. Afraid that 
compliance and adherence is not achieved 
HCPs´ role: Understand when and how to provide PrEP. Understand that PrEP is only an additional tool for condoms. Recommend 
PrEP to people with fatalism regarding HIV and that they would not use condoms anyway. Ethical dilemma of nurses whether or 
not to recommend PrEP, a relatively expensive medication to the population. Moreover, principles of social justice take place when 
nurses need to consider whether to only recommendation PrEP to those who can adhere and follow-up with treatment while 
neglecting the ones who can´t, in which PrEP might still be of benefit to them.  Nurses must decide to whom we should recommend 
PrEP to and based on what evidence based criteria. It is recommended to reach out to those most in need and most mistreated by the 
system. For example, help out those whose insurance doesn´t cover PrEP by introducing them to aiding programs. Nurses need to 
get the sexual anamneses of the patients. Patient education and follow-up is a compulsory for PrEP.  It is important to know that 
not only gay men who are at risk of HIV, many heterosexuals are as well. 
7 HIV risk: MSM are more likely to acquire HIV. Risky behavior: IDUs. 
Information about PrEP: Approved by FDA for HIV prevention tool. PrEP knowledge of HCPs is high to medium. Uptake of 
PrEP is low 
Challenge: Faced by HCPs: lack of guidance, cost, lack of confidence in real-world effectiveness, patient´s adherence, risk 
compensation and drug resistance. Social justice: PrEP diverts resources away from HIV positive people. Faced by patients: 
Adherence  
HCPs´ role: HCPs play an important role in the implementation and provision of PrEP.  
8 HIV risk: MSM, black MSM and sex workers are at high risk of HIV.  
Information about PrEP: PrEP knowledge and uptake is low from those at risk. HCPs are not aware nor provide information about 
PrEP. 
HCPs´ role: Provide patients at high risk information about PrEP. Community nurses are in a perfect position to promote PrEP. 
Nurses need education about PrEP. Incorporate the topic of PrEP during HIV testing for high-risk patients.   
9 HIV risk: MSM, HIV negative sex partners of HIV positive people, transgendered are at high risk of HIV.  
Information about PrEP: FDA approved PrEP and recommended by WHO. Uptake of PrEP is low  
Challenge: faced by the patients: adherence, stigma (whore, peers, homosexual, sex work, assume HIV positive, non-disclosure, 
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sex outside relationship, mistrust in HCPs etc.), no stigma in discordant couples. Face by HCPs – Risk compensation, drug 
resistance, real-world efficacy, adherence, moral issues, and guidelines. 
HCPs´ role: frequent monitoring for PrEP users. PrEP should be recommended to help people remain HIV – negative.  
10 HIV risk: MSM, transgender, heterosexual serodiscordant couples are at higher risk of HIV 
Information about PrEP: Approved by FDA and recommended by CDC.  
Challenge: adherence to the dosage.  
HCPs´ role: Adherence intervention by education (printed materials, discussion, signs, and symptoms, etc.), counseling, home-based 
rapid HIV testing, feedback (follow-up: phone calls, SMS). 
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Appendix 4 
Table 5 Answers to each research questions by each article 
Articles  1. What role does PrEP 
play in HIV prevention? 
2. What are the 
challenges 
nurses face 
when 
encountering 
patients with 
high risk for 
HIV 
acquisition?  
3. What are the 
recommendations to 
combat the challenges 
nurses face during care 
encounter?  
1 Considering the fact that 
heterosexual, Black and young 
women are at high risk of contracting 
HIV, PrEP approved by FDA can 
effectively help these target groups 
avoiding HIV transmission.  
 Spread accurate information about PrEP 
to high-risk patients while building trust 
with the patients. 
2 Transgender are at higher risk of 
HIV due to biological, psychological 
and environmental factors. Sex work 
in transgender is also a risky 
behavior. However, it is still 
debatable whether the FDA approved 
PrEP would be beneficial for this 
community on the large scale.  
 Recommend condoms, PrEP, stable 
partners as well as HIV treatment for 
positives partners. Nurses should 
connect trans patients to the community 
and appropriate medical services.   
3 PrEP approved by FDA and 
recommended by CDC should be 
promoted to HIV negative partners 
with serodiscordant heterosexual 
couples who are at high risk for HIV 
as well as African and Latino. 
Surprisingly, Transmission is higher 
for women with a primary male 
partner. 
Fear of drug resistance in 
the case of acute HIV 
patients who are not 
aware of their infection. 
PrEP encourages fewer 
condoms use in 
serodiscordant couples. 
Many HCPs only treat 
HIV positive patients and 
they lack confidence in 
PrEP real-world 
effectiveness.  
Provide information about PrEP to HIV 
neg patient in the clinical setting when 
treating the HIV positive partner. 
4 The CDC recommends PrEP for 
IDUs when condoms and clean 
needles are not available to prevent 
HIV transmission. 
 It is proposed to only recommend PrEP 
to IDUs at certain high risk of HIV like 
IDUs of risky sexual behaviors, needle 
sharing, and drug mixing. Nurses should 
be aware of the cooperation between 
MMT, PrEP and ART programs. The 
issue of cost-effectiveness makes nurses 
face dilemma when public budget does 
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not allow them to recommend PrEP to 
every IDUs despite the fact that PrEP 
might be of help to these patients 
5 PrEP promotion is essential for 
MSM that are at high risk of HIV. 
PrEP knowledge from both patients 
and HCPs is low, hence promotion 
regarding this topic is to be 
emphasized.  
 HIV testing, condom education, and risk 
reduction counseling. The role of 
community empowerment is 
emphasized, therefore community nurses 
play a big role in PrEP. Nurses need to 
receive education about PrEP. It is 
important for nurses to identify 
individuals at high risk for HIV. 
Behavioral intervention can be used such 
as maintaining the relationship with the 
patients and assisting them with adhering 
to the medicine as well as HIV and STIs 
testing. Referring the patients to safe 
space community like LGBTQ 
organisations where PrEP can be 
promoted for high-risk individuals.   
6 PrEP approved by FDA, should be 
promoted to those who use needle 
stick or having unprotected 
condomless sex as well as MSM and 
young MSM of color who are at 
higher risk of HIV. 
Patients who do not 
adhere to the daily 
dosage as well as frequent 
check-up which can 
potentially lead to med 
failure and drug 
resistance. Many MSM 
admit that they are not 
planning to use condoms 
while on PrEP.  
Understand when and how to provide 
PrEP. Understand that PrEP is only an 
additional tool for condoms. 
Recommend PrEP to people with 
fatalism regarding HIV and that they 
would not use condoms anyway. Ethical 
dilemma of nurses whether or not to 
recommend PrEP, a relatively expensive 
medication to the population. Moreover, 
principles of social justice takes place 
when nurses need to consider whether to 
only recommendation PrEP to those who 
can adhere and follow-up with treatment 
while neglecting the ones who can´t, in 
which PrEP might still be of benefit to 
them.  Nurses must decide to whom we 
should recommend PrEP to and based on 
what evidence-based criteria. It is 
recommended to reach out to those most 
in need and most mistreated by the 
system. For example, help out those 
whose insurance doesn´t cover PrEP by 
introducing them to aiding programs. 
Nurses need to get the sexual anamneses 
of the patients. Patient education and 
follow-up is compulsory for PrEP.  It is 
important to know that not only gay men 
who are at risk of HIV, many 
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heterosexuals are as well. 
7 PrEP approved by FDA and 
recommended by the CDC, should be 
provided to those at high risks like 
MSM and IDUs. It is found that 
patients who are interested in PrEP 
are likely to have high drug 
adherence. 
Doctors are reluctant to 
prescribe the med due to 
fear of drug resistance. 
The increase of STIs 
derived from PrEP is a 
concern for many HCPs. 
Many HCPs only treat 
HIV positive patients and 
they lack confidence in 
PrEP real world 
effectiveness. Moreover, 
there is lack of local 
guidance on the topic.  
HCPs play an important role in the 
implementation, promotion, and 
provision of PrEP. 
8 PrEP should be promoted to MSM, 
black MSM and sex workers who are 
at high risk of HIV but whose 
knowledge and uptake of PrEP is still 
low.  
 Provide patients at high risk 
information about PrEP. Community 
nurses are at perfect position to promote 
PrEP. Nurses need education about 
PrEP. Incorporate the topic of PrEP in 
HIV testing for high-risk patients.   
9 PrEP should be recommended for 
MSM, HIV negative sex partners of 
HIV positive people, transgendered 
are at high risk of HIV. Uptake of 
PrEP is still low.  
Many HCPS are 
concerned about PrEP 
leads to risk 
compensation such as a 
decrease in condom use 
and increase in STIs. 
Risk compensation 
stereotype manifests in 
many HCPs´ opinion 
about Black HIV negative 
partners. Some HCPs 
perceive CDC´s 
guidelines to be 
ambiguous.  
Frequent monitoring of PrEP users. PrEP 
should be recommended to help people 
remain HIV – negative. 
10 PrEP should be recommended for 
transgender, heterosexual 
serodiscordant couples who are at 
higher risk of HIV. PrEP is approved 
by FDA and recommended by CDC 
 
 Adherence intervention by education 
(printed materials, discussion, signs, and 
symptoms, etc.), counseling, home/based 
rapid HIV testing, feedback (follow-up: 
phone calls, SMS). 
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Appendix 5 
Table 6 Brief findings of 10 unit of analysis 
Major category HIV Risk 
Minor categories  Gender and sexuality Race  Risky behaviors  
Findings  Women, MSM, 
Transgender 
Black, Hispanic IDUs, substance misuse, drugs, sex work, HIV-
discordant couples, receptive anal condomless 
sex, frequent change of partner, etc 
Unit of analysis  1, 2, 3, 5, 7, 8, 9, 10 1, 3, 6, 8 2, 3, 4, 6, 7, 9, 10 
 
Major category Information about PrEP 
Minor categories  PrEP benefit PrEP knowledge 
from patients 
PrEP knowledge 
from HCPs  
PrEP demand  PrEP 
uptake 
Findings  FDA approved, CDC 
guidelines, WHO 
recommended, HIV 
prevention 
Low Low, medium to 
high 
High low 
Unit of analysis  1, 2 (open question for 
transgender), 3, 4, 5, 
6, 7, 8, 9, 10 
1, 5, 8 
 
Low: 1, 5, 6, 8 
High in the US: 7 
Medium outside 
U.S: 7 
1, 3, 7,9 1, 3, 5, 7, 8, 
9 
 
Major 
category 
Challenge faced by the patients (part 1) 
Minor 
categories  
Cost Long-term 
effects 
Peer influence Mistrust  Stigma 
Findings  High, 
depending on 
where the 
patients are, 
America needs 
insurance, free 
in some 
countries    
Renal 
disease, 
bone 
disease, 
bone 
density    
partners, friends Mistrust in healthcare 
professional and the 
medicine 
Misperceive of 
HIV positive, 
discrimination, 
depression, 
promiscuous, risky 
behaviors     
Unit of 
analysis  
1, 2, 3, 4 3, 6 
 
3, 9 1, 9 1, 2, 3, 9 
 64 
 
 
 
Major category Challenge faced by the patients (part 2) 
Minor categories  Side effects Adherence  Follow up 
Findings  drug-drug interaction (nephrotoxic drugs, 
contraceptives), nausea, abdominal 
cramping, vomiting, dizziness, headache, etc.   
A great challenge for 
many PrEp users, all 
challenges discussed 
could play as 
potential barriers to 
adherence    
Personal circumstances like 
poverty, mental health, etc 
Unit of analysis  1, 3, 6 
 
1, 3, 4, 7, 9 3 
 
Major category Challenge faced by HCPs 
Minor categories  Drug resistance Risk compensation Attitude Guidance 
 
Findings  Fear of drug 
resistance   
decrease condom use, 
increase STIs 
PrEP not relevant to 
their care, lack of 
confidence in real- 
world effectiveness, 
not supportive   
lack of guidance 
 
Unit of analysis 3, 6, 7, 3, 6, 7, 9 (unconscious 
bias)  
3, 7 7, 9 
 
 
Major category Recommendation for HPCs (part 1) 
Minor categories  Information delivery 
and patient education 
Build a trusting 
relationship with the 
patients 
Community 
empowerment 
Adherence and follow 
up support 
Findings Patients need to know 
about all possible 
options including PrEP 
and other interventions, 
rich out for those at 
high risk 
open communication 
with the patients about 
their sexual activities, 
risk evaluation and 
possible for PrEP    
HCPs can connect 
high-risk patients to 
advocacy communities 
with a support network. 
This is effective for 
HIV prevention and 
PrEP uptake   
key to the effectiveness 
of the prevention, 
counseling, feedback, 
phone calls     
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Unit of analysis 1 3 5 6 8, 9, 10 
 
1, 7 2 5 8 
 
4 6 10 
 
Major category Recommendation for HPCs (part 2) 
Minor categories  Risk evaluation Social justice PrEP education for 
HCPs 
HIV testing and PrEP 
Findings HCPs should evaluate 
the risk of contracting 
HIV of the patients to 
consider suggesting 
PrEP 
Support those who are 
mistreated by the 
healthcare system, not 
covered by insurance, 
those subjected to 
prejudices      
HCPs need training 
about this alternative 
HIV prevention method 
in addition to condoms 
Integrate PrEP with 
HIV testing (talk about 
PrEP at HIV testing 
and HIV testing while 
taking PrEP) 
Unit of analysis 4, 5, 6, 7 6, 7 7, 8 
 
3, 5, 8, 10 
 
